Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BBNX

Beta Bionics Inc

Mar 26 • 04:00PM ET

13.15

Dollar change -2.07
Percentage change -13.60	%

Healthcare • Medical Devices • USA • NASD

Held by: IWM IWO SCHA IWN VTI VXF SCHB RSSL IWV VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-	Insider Own	18.78%	Shs Outstand	43.35M	Perf Week	-16.72%
Market Cap	569.79M	Forward P/E	-	EPS next Y	-1.93	Insider Trans	14.55%	Shs Float	35.19M	Perf Month	-31.40%
Income	-	PEG	-	EPS next Q	-0.47	Inst Own	38.04%	Short Float	3.43%	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	78.87%	Inst Trans	73.19%	Short Ratio	1.90	Perf Half Y	-
Book/sh	-5.66	P/B	-	EPS next Y	-6.29%	ROA	-	Short Interest	1.21M	Perf Year	-
Cash/sh	2.39	P/C	5.50	EPS next 5Y	38.50%	ROE	-	52W Range	13.64 - 24.50	Perf YTD	-44.35%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-46.33%	Beta	-
Dividend TTM	-	Quick Ratio	5.66	Sales past 5Y	3522.02%	Gross Margin	-	52W Low	-3.59%	ATR (14)	1.46
Dividend Ex-Date	-	Current Ratio	6.29	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	26.74	Volatility	9.38% 9.91%
Employees	291	Debt/Eq	0.10	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.29	Target Price	26.14
Option/Short	No / Yes	LT Debt/Eq	0.08	EPS Q/Q	-	Payout	-	Rel Volume	1.83	Prev Close	15.22
Sales Surprise	1.22%	EPS Surprise	-202.22%	Sales Q/Q	-	Earnings	Mar 25 AMC	Avg Volume	635.10K	Price	13.15
SMA20	-19.77%	SMA50	-31.29%	SMA200	-31.29%	Trades		Volume	1,162,585	Change	-13.60%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-25	Initiated	Stifel	Buy	$25
Feb-24-25	Initiated	Piper Sandler	Overweight	$26
Feb-24-25	Initiated	Leerink Partners	Outperform	$28
Feb-24-25	Initiated	Lake Street	Buy	$30
Feb-24-25	Initiated	BofA Securities	Buy
Feb-20-25	Initiated	Robert W. Baird	Neutral	$20
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral	$20

Mar-25-25 04:02PM	Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 (GlobeNewswire) -13.60%
Mar-03-25 12:59PM	Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-27-25 07:00AM	Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 (GlobeNewswire)
Feb-21-25 09:35AM	Palantir initiated, Roku upgraded: Wall Streets top analyst calls (TipRanks)
Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Loading…
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mensinger Mike	Chief Product Officer	Jan 31 '25	Buy	17.00	33,350	566,950	59,019	Feb 03 08:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Sale	17.00	13	221	25,669	Feb 03 08:30 PM
Wellington Hadley Harbor Aggre	10% Owner	Jan 31 '25	Buy	17.00	1,000,000	17,000,000	3,901,599	Feb 03 04:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your FINVIZ experience